Active	Status	Sponsor type	Region	Phase	Filter
31 Active 49 Inactive 80 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

31 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kreuter, Michael
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	Active, not recruiting	3	160	Europe, Canada, Japan, US, RoW	Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo	Savara Inc., Savara ApS,	Autoimmune Pulmonary Alveolar Proteinosis	11/23	11/24
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease	Recruiting	3	440	Europe, Japan, US, RoW	Belimumab, BENLYSTA, GSK1550188, Placebo	GlaxoSmithKline	Lung Diseases, Interstitial	10/28	12/28
NCT05130970 / 2021-003162-12: Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis	Completed	2	81	Europe, Canada, US, RoW	Garadacimab, Factor XIIa antagonist monoclonal antibody, CSL312, Placebo	CSL Behring	Idiopathic Pulmonary Fibrosis	01/24	01/24
I-FILE, NCT04304898: An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology	Recruiting	N/A	700	Europe	Home spirometry	Erasmus Medical Center	Pulmonary Fibrosis	07/25	07/26
ILDnose, NCT04680832: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD	Recruiting	N/A	600	Europe	Electronic nose, SpiroNose, eNose	Erasmus Medical Center	Pulmonary Fibrosis	12/25	12/26
Herth, Felix JF
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP	Active, not recruiting	3	1667	Europe, Canada, Japan, US, RoW	GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)	GlaxoSmithKline, Iqvia Pty Ltd	Asthma	10/25	10/25
RECOVER, NCT05200754: Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19	Recruiting	2	174	Europe	Convalescent/Vaccine-boosted Plasma (CP/PVP)	Carsten Müller-Tidow, German Federal Ministry of Education and Research, Institut für Klinische Transfusionsmedizin und Zelltherapie Heidelberg gGmbH	SARS-CoV-2 Infection	04/22	06/22
NCT06317285: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)	Recruiting	2	150	Europe, Canada, US, RoW	GSK3915393, Placebo	GlaxoSmithKline	Idiopathic Pulmonary Fibrosis	03/26	03/26
NCT03685526: Cinenses Lung Volume Reduction Reverser System First-in-man Study Treating Patients With Severe Emphysema	Active, not recruiting	N/A	15	Europe	Cinenses Lung Volume Reduction Reverser System	Lifetech Scientific (Shenzhen) Co., Ltd.	Emphysema	10/21	08/22
EFFORT, NCT04520152: Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema	Completed	N/A	14	Europe	FreeFlowMedical Lung Tensioning Device	University Medical Center Groningen	Emphysema or COPD	11/23	11/23
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
IAB-1, NCT05087641: A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema	Active, not recruiting	N/A	20	Europe, RoW	IAB System	Pulmair Medical, Inc.	Emphysema, Pulmonary Disease, Chronic Obstructive	04/24	01/27
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis	Active, not recruiting	N/A	270	Europe, US	RheOx Bronchial Rheoplasty, Sham Procedure	Gala Therapeutics, Inc.	Chronic Bronchitis	05/24	10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
NCT04182841: RheOx Registry Study in Europe	Recruiting	N/A	100	Europe	RheOx	Gala Therapeutics, Inc.	Chronic Bronchitis, COPD	12/24	12/25
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema	Recruiting	N/A	30	Europe	Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction	Morair Medtech, LLC	Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)	02/26	05/26
NCT03318406: Post-Market BTVA Registry	Recruiting	N/A	300	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor	Uptake Medical Technology, Inc.	Emphysema or COPD	12/27	12/30
NCT05717192: BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation	Recruiting	N/A	224	Europe	InterVapor®-System	IHF GmbH - Institut für Herzinfarktforschung	Emphysema or Chronic Obstructive Pulmonary Disease	04/26	12/27
Eberhardt, Ralf
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema	Recruiting	N/A	200	Europe, US, RoW	AeriSeal System	Pulmonx Corporation	Emphysema, Pulmonary, Emphysema or COPD	06/27	03/28
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema	Recruiting	N/A	30	Europe	Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction	Morair Medtech, LLC	Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)	02/26	05/26
NCT03318406: Post-Market BTVA Registry	Recruiting	N/A	300	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor	Uptake Medical Technology, Inc.	Emphysema or COPD	12/27	12/30
NCT05717192: BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation	Recruiting	N/A	224	Europe	InterVapor®-System	IHF GmbH - Institut für Herzinfarktforschung	Emphysema or Chronic Obstructive Pulmonary Disease	04/26	12/27
Gompelmann, Daniela
NCT04824495: Evaluation of Inflammatory Cytokines During COVID-19	Recruiting	N/A	100	Europe	Blood sample	University of Vienna	Covid19	08/21	12/21
NCT04827667: Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer	Recruiting	N/A	40	Europe	bronchoalveolar lavage	University of Vienna	Lung Cancer	09/21	12/21
NCT03609541: Evaluation of Biomarkers of COPD Exacerbation	Recruiting	N/A	80	Europe		Heidelberg University	SAA Level and SAA/Lipoxin A4 Ratio	06/23	06/23
NCT06056882: Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules	Recruiting	N/A	20	Europe	CLE-guided cryobiopsy	University of Vienna	Pulmonary Disease	03/24	06/24
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema	Recruiting	N/A	30	Europe	Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction	Morair Medtech, LLC	Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)	02/26	05/26
CLEVER, NCT06079970: Confocal Laser Endomicroscopy VERification	Recruiting	N/A	208	Europe, US, RoW	Neelde Based Confocal Laser Endomicroscopy, Conventional diagnostic bronchoscopy	Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Mauna Kea Technologies	Lung Cancer, Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, Neoplasm of Lung	10/25	10/25
NCT04834830: Evaluation and Importance of the PD-1/PD-L1 and the IL-10/IL-10R Axis in Malignant and Benign Pleural Effusions - a Pilot Study	Recruiting	N/A	80	Europe	Pleural effusion will be examined for various cytokines and PD1-lymphocytes.	University of Vienna	Pleural Effusion	04/22	04/22
Ozturk-Sarioglu, Sevilay
CONVERT, NCT04559464: Fissure Closure With the AeriSeal System for ing Collateral Ventilation Status	Completed	N/A	102	Europe, RoW	AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System	Pulmonx Corporation	Emphysema, COPD, Severe Emphysema	10/23	10/24